Cargando…
Inflammatory Remission in T2 Severe Asthma
Autores principales: | Rial, Manuel J., Domínguez-Ortega, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234872/ https://www.ncbi.nlm.nih.gov/pubmed/35769583 http://dx.doi.org/10.3389/falgy.2022.923083 |
Ejemplares similares
-
Immunobiology of Steroid-Unresponsive Severe Asthma
por: Marshall, Courtney Lynn, et al.
Publicado: (2021) -
COVID-19, Eosinophils, and Biologicals for Severe Asthma
por: Lombardi, Carlo, et al.
Publicado: (2022) -
Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
por: López-Viña, Antolín, et al.
Publicado: (2022) -
Asthma improvement in patients treated with dupilumab for severe atopic dermatitis
por: Dubini, Marco, et al.
Publicado: (2023) -
Corrigendum: Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach
por: López-Viña, Antolín, et al.
Publicado: (2023)